Gun H. Jang

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer.

Deep Learning of Histopathology Predicts Outcomes After Surgery for Pancreatic Cancer.

Journal: JCO clinical cancer informatics

Published: April 29, 2026

Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

Erratum: PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 24, 2025

PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

PASS-01: Randomized Phase II Trial of Modified FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel and Molecular Correlatives for Previously Untreated Metastatic Pancreatic Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 10, 2025

Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare System.

Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare System.

Journal: Current oncology (Toronto, Ont.)

Published: December 23, 2024

Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial.

Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial.

Journal: Nature communications

Published: November 20, 2024

nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancer.

nSMase2-mediated exosome secretion shapes the tumor microenvironment to immunologically support pancreatic cancer.

Journal: bioRxiv : the preprint server for biology

Published: October 14, 2024

HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity.

HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity.

Journal: Nature communications

Published: August 28, 2024

The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer.

The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer.

Journal: NPJ precision oncology

Published: August 04, 2024

HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma.

HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 10, 2024

Relative Belief Inferences from Decision Theory.

Relative Belief Inferences from Decision Theory.

Journal: Entropy (Basel, Switzerland)

Published: June 13, 2024

Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma.

Multi-omics whole-genome characterization of the copy number landscape of metastatic pancreatic ductal adenocarcinoma.

Journal: iScience

Published: May 30, 2024

MICAL2 Promotes Pancreatic Cancer Growth and Metastasis.

MICAL2 Promotes Pancreatic Cancer Growth and Metastasis.

Journal: Cancer research

Published: March 04, 2024

Showing 1-12 of 52

Last Updated: 09/26/2026